Pasithea Therapeutics Corp. (KTTA)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pasithea Therapeutics Corp.’s names, not what it holds today.
0 published
1 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 19, 2015 | 9,034,861 | MEK inhibitors useful in the treatment of diseases | Pharmaceuticals | Allomek Therapeutics LLC |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 22, 2024 | 2024/0279345 | ALPHA 5 BETA 1 INTEGRIN BINDING AGENTS AND USES THEREOF | Biotechnology | PASITHEA THERAPEUTICS CORP. |
| Sep 10, 2015 | 2015/0250762 | NOVEL MEK INHIBITORS FOR TREATING CARDIOMYOPATHIES AND RELATED CONDITIONS | Organic fine chemistry | Allomek Therapeutics LLC |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.